1. Skip to header
  2. Skip to main
  3. Skip to content
  4. Skip to sidebar
  5. Skip to footer
Kenneth R. Hande, M.D.

Kenneth R. Hande, M.D.

Contact Address
Vanderbilt-Ingram Cancer Center
691 Preston Building
Nashville, TN
Contact Phone
(615) 322-4967
Professional Affiliations
  1. Vanderbilt-Ingram Cancer Center
    Position held:  Medical Oncologist

  3. Vanderbilt-Ingram Cancer Center
    Position held:  Director
    Program:  Fellowship Program

Expertise
  1. Adrenocortical Cancer
  2. Anal Cancer
  3. Bile Duct (Extrahepatic) Cancer
  4. Carcinoma of Unknown Primary
  5. Colon Cancer
  6. Esophageal Cancer
  7. Gallbladder Cancer
  8. Islet Cell Cancer (Pancreas)
  9. Liver Cancer
  10. Non-Small Cell Lung Cancer
  11. Small Cell Lung Cancer
  12. Mesothelioma
  13. Pancreatic Cancer
  14. Rectal Cancer
  15. Small Intestine Cancer
  16. Soft Tissue Sarcoma
  17. Stomach (Gastric) Cancer
  18. Thymoma and Thymic Carcinoma
Education
  1. Johns Hopkins University, M.D.,  1972
  2. Washington University, Postgraduate Training, 
  3. National Cancer Institute, Postgraduate Training, 
Appointments
    Professor of Medicine and Pharmacology Vanderbilt-Ingram Cancer Center,  
Website
(will open new window)
Biography

Dr. Hande is a medical oncologist who specializes in the treatment of carcinoma of the unknown primary site, phase I drug development, carcinoid tumors, lung cancer and sarcomas. His clinical research interests are in the pharmacology of drugs used in cancer therapy with a focus in the metabolism, elimination, toxicity and efficacy of antineoplastic agents. He is also involved in Phase I studies looking at the toxicity optimal dosing and pharmacokinetics of new drugs or drug combinations.

As Director of the Division's Fellowship Program, he is extensively involved in training physicians to become specialists in hematology and oncology. In this role, Dr. Hande develops and oversees a training program that includes all aspects of clinical hematology/oncology and laboratory-based research opportunities.

In 2003, Dr. Hande was listed as one of the "top doctors" in the nation in America's Top Doctors rankings.

Mesothelioma and Lung Cancer Specialists at
Vanderbilt-Ingram Cancer Center

  • David Carbone, M.D., Ph.D. Harold L. Moses Chair in Cancer Research, Ingram Professor of Cancer Research, Director of Specialized Program of Research Excellence in Lung Cancer, Director of the Experimental Therapeutics Program
  • David Johnson, M.D. Medical Oncologist, Cornelius Abernathy Craig Professor of Medical and Surgical Oncology, Director Division of Hematology/Oncology
  • Eric Lambright, M.D. Surgical Director Lung Transplant, Thoracic Surgeon
  • Pierre Massion, M.D. Pulmonary and Critical Care Medicine Doctor
  • Joe Putnam, M.D. Thoracic Surgeon
  • Alvan Sandler, M.D. Medical Director Thoracic Oncology, Director anderbilt-Ingram Cancer Center Affiliate Network Program, Medical Oncologist